Published in Immunology on December 01, 1972
Normal and pathological serum levels of alpha2-macroglobulins in men and mice. J Clin Pathol (1975) 1.18
The effect of antilymphocytic antibody on the humoral immune response in different strains of mice. 3. The response to type 3 pneumococcus polysaccharide. Immunology (1973) 0.97
Effect of antithymocyte serum on reaginic antibody formation in the rat. Immunology (1974) 0.95
The effect of antilymphocytic antibody on the humoral immune response of different strains of mice. V. Effects on the class and subclass of antibody produced, and the antibody responses of congenitally athymic mice. Clin Exp Immunol (1974) 0.86
Natural cathepsin E deficiency in the immune system of C57BL/6J mice. Immunogenetics (2007) 0.86
The effect of transplanted methylcholanthrene induced fibrosarcomata and Corynebacterium parvum on the immune response of CBA and A-HeJ mice to thymus dependent and independent antigens. Br J Cancer (1974) 0.84
The effect of antilymphocytic antibody on the humoral immune response of different strains of mice. IV. Variable effect of individual ALG preparations on the immune response to type 3 polysaccharide antigen. Immunology (1974) 0.80
The effect of human alpha 2-macroglobulin on the restoration of humoral responsiveness in x-irradiated mice. Clin Exp Immunol (1975) 0.75
Further studies on the effect of a transplanted methylcholanthrene-induced fibrosarcoma on humoral immunity in CBA mice. Clin Exp Immunol (1974) 0.75
Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature (1962) 64.93
A quantitative immunochemical measure of the primary interaction between I BSA and antibody. J Infect Dis (1959) 22.10
Cellular cooperation in the antibody response of mice to two serum albumins: specific function of thymus cells. Transplant Rev (1969) 5.38
Thymus dependence of antibody response: variation with dose of antigen and class of antibody. Nature (1968) 3.79
Enhancement of the antibody response to type 3 pneumococcal polysaccharide in mice treated with antilymphocyte serum. J Immunol (1970) 2.59
Antibody production studied by means of the localized haemolysis in gel (LHG) assay. 3. Mouse cells producing five different classes of antibody. Immunology (1969) 2.04
Comparison of the immune responsiveness of NZB and NZB X NZW F1 hybrid mice with that of other strains of mice. J Exp Med (1969) 1.87
Variable effects of anti-lymphocyte serum on humoral antibody formation: role of thymus dependency of antigen. J Immunol (1971) 1.80
Quantitative estimation of antibody in the immunoglobulin classes of the mouse. II. Thymic dependence of the different classes. J Immunol (1972) 1.73
The effect of pertussis vaccine on the immune response of mice to sheep red blood cells. Clin Exp Immunol (1970) 1.56
Some factors influencing the ability of anti-lymphocytic antibody to suppress humoral antibody formation. Clin Exp Immunol (1967) 1.52
Review lecture. Immunosuppressive agents, with special reference to antilymphocytic serum. Proc R Soc Lond B Biol Sci (1969) 1.52
The preparation and properties of anti-lymphocytic sera. Prog Surg (1969) 1.48
Time-dependent immunosuppressive effects of anti-thymocyte serum. Nature (1967) 1.48
Neonatal thymectomy and the decrease in antigen-sensitivity of the primary response and immunological "memory" systems. Immunology (1968) 1.46
Quantitative estimation of antibodies in the immunoglobulin classes of the mouse. I. Effect of adjuvants on the antibody response to human serum albumin and keyhole limpet haemocyanin. Clin Exp Immunol (1972) 1.44
Effect of anti-rat lymphocyte antibody on humoral antibody formation. Nature (1967) 1.40
The carrier effect in the secondary response to hapten-protein conjugates. V. Use of antilymphocyte serum to deplete animals of helper cells. Eur J Immunol (1971) 1.29
Effects of antimacrophage, antithymocyte, antilymphocyte and antispleen serum on the immune response in mice. Clin Exp Immunol (1970) 1.05
The effects of ALG on the murine immune response to sheep erythrocytes. Immunology (1972) 1.01
Circulating antibody and anaphylaxis in mice. J Immunol (1961) 1.01
Biological effects of heterologous antilymphocyte serum. Prog Allergy (1970) 0.98
The effect of antilymphocytic antibody on the primary immune response of mice to sheep erythrocytes, bovine serum albumin, and type 3 pneumococcus polysaccharide. Transplantation (1971) 0.94
Strain variations in the primary humoral response of rats and its susceptibility to inhibition by anti-lymphocytic antibody. Nature (1969) 0.92
Effect of adjuvants on the immunosuppressive properties of antilymphocytic globulin. Nature (1970) 0.85
The effect of heterologous antilymphocyte serum (ALS) on the humoral antibody response to Salmonella typhi "H" antigen and bovine serum albumin. J Immunol (1970) 0.85
The genome sequence of Schizosaccharomyces pombe. Nature (2002) 14.26
The genome of the social amoeba Dictyostelium discoideum. Nature (2005) 9.18
BioJava: an open-source framework for bioinformatics. Bioinformatics (2008) 6.17
Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results. J Natl Cancer Inst (2000) 5.62
Anti-lymphocytic antibody--a review. Clin Exp Immunol (1967) 2.75
BCG immunotherapy of bladder cancer: 20 years on. Lancet (1999) 2.38
Human monoclonal antibody production. Current status and future prospects. J Immunol Methods (1987) 2.21
Laboratory staff qualifications and accuracy of proficiency test results. A national study. Arch Pathol Lab Med (1992) 2.07
The natural history of Peyronie's disease. J Urol (1990) 2.02
Effect of antilymphocytic antibody and antibody fragments on human lymphocytes in vitro. Nature (1967) 1.89
Psychotic men remanded in custody to Brixton Prison. Br J Psychiatry (1994) 1.77
Circadian variation of lymphocyte subpopulations: a study with monoclonal antibodies. Br Med J (Clin Res Ed) (1983) 1.72
Long-term follow-up confirms a survival advantage of the paclitaxel-cisplatin regimen over the cyclophosphamide-cisplatin combination in advanced ovarian cancer. Int J Gynecol Cancer (2003) 1.70
Radio-immunoassay detection of interferon-gamma in urine after intravesical Evans BCG therapy. J Urol (1990) 1.66
Randomized study of CODE versus alternating CAV/EP for extensive-stage small-cell lung cancer: an Intergroup Study of the National Cancer Institute of Canada Clinical Trials Group and the Southwest Oncology Group. J Clin Oncol (1999) 1.63
A genomewide suppressor and enhancer analysis of cdc13-1 reveals varied cellular processes influencing telomere capping in Saccharomyces cerevisiae. Genetics (2008) 1.58
Some factors influencing the ability of anti-lymphocytic antibody to suppress humoral antibody formation. Clin Exp Immunol (1967) 1.52
Function and health status outcomes in a randomized trial comparing preoperative and postoperative radiotherapy in extremity soft tissue sarcoma. J Clin Oncol (2002) 1.50
The preparation and properties of anti-lymphocytic sera. Prog Surg (1969) 1.48
[Surgical treatment of the single non traumatic perforation of small bowel: excision-suture or resection-anastomosis]. Ann Chir (2005) 1.45
Melatonin administration can entrain the free-running circadian system of blind subjects. J Endocrinol (2000) 1.43
Structure-property correlations in a combinatorial library of degradable biomaterials. J Biomed Mater Res (1998) 1.42
Continuous thoracic epidural analgesia versus combined spinal/thoracic epidural analgesia on pain, pulmonary function and the metabolic response following colonic resection. Acta Anaesthesiol Scand (1996) 1.42
Effect of antilymphocytic antibody and antibody fragments on skin-homograft survival and the blood-lymphocyte count in rats. Lancet (1967) 1.41
Effect of anti-rat lymphocyte antibody on humoral antibody formation. Nature (1967) 1.40
Early history of veterinary education in Victoria. Aust Vet J (1992) 1.39
Intravesical Evans strain BCG therapy: quantitative immunohistochemical analysis of the immune response within the bladder wall. J Urol (1992) 1.38
Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. The National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol (1996) 1.32
The James Lind Library: explaining and illustrating the evolution of fair tests of medical treatments. J R Coll Physicians Edinb (2008) 1.29
Effects of ascertainment bias and marker number on estimations of barley diversity from high-throughput SNP genotype data. Theor Appl Genet (2010) 1.28
Characterization of antilymphocytic antibody. Nature (1967) 1.27
Quality-adjusted time without symptoms or toxicity analysis of interferon maintenance in multiple myeloma. J Clin Oncol (1998) 1.27
Characterization of symptomatic and asymptomatic carotid plaques using high-resolution real-time ultrasonography. Br J Surg (1993) 1.26
The distribution and possible significance of cells identified in human lymphoid tissue by the monoclonal antibody HNK-1. Clin Exp Immunol (1983) 1.25
Multiple organ damage caused by a new toxin azaspiracid, isolated from mussels produced in Ireland. Toxicon (2000) 1.23
New allele at cholinesterase locus 1. J Med Genet (1976) 1.20
Normal and pathological serum levels of alpha2-macroglobulins in men and mice. J Clin Pathol (1975) 1.18
Prolongation of canine renal allograft survival with antilymphocytic serum. Transplantation (1968) 1.16
Changes in urinary cytokines and soluble intercellular adhesion molecule-1 (ICAM-1) in bladder cancer patients after bacillus Calmette-Guérin (BCG) immunotherapy. Clin Exp Immunol (1995) 1.14
Flexible eating and flexible insulin dosing in patients with diabetes: Results of an intensive self-management course. Diabetes Res Clin Pract (2008) 1.13
Quantitative studies with antilymphocytic antibody. Nature (1967) 1.13
The antecedents of violence and aggression within psychiatric in-patient settings. Acta Psychiatr Scand (2012) 1.10
Studies on a unique diagnostic serum globulin in papular mucinosis (lichen myxedematosus). Clin Exp Immunol (1967) 1.10
William Cullen and a missing mind-body link in the early history of placebos. J R Soc Med (2008) 1.10
Collagenase versus placebo in the treatment of Peyronie's disease: a double-blind study. J Urol (1993) 1.08
Binding of C-reactive protein to human lymphocytes. II. Interaction with a subset of cells bearing the Fc receptor. J Immunol (1981) 1.08
Preliminary observations on the effect of heterologous anti-lymphocytic globulin on autologous immune complex nephritis in rats. Clin Exp Immunol (1969) 1.06
Mechanisms of action of intravesical bacille Calmette-Guérin: local immune mechanisms. Clin Infect Dis (2000) 1.06
Binding of C-reactive protein to human lymphocytes. I. Requirement for a binding specificity. J Immunol (1981) 1.05
Dose-response relationship for risk of non-vertebral fracture with inhaled corticosteroids. Clin Exp Allergy (2008) 1.05
Distribution of fatty and fibrous plaques in young human coronary arteries. Atherosclerosis (1982) 1.05
Role for CD40-CD40 ligand interactions in the immune response to solid tumours. Mol Immunol (2000) 1.05
A membrane-covered photobacterium probe for oxygen measurements in the nanomolar range. Anal Biochem (1981) 1.04
Prediction of amputation wound healing with skin perfusion pressure. J Vasc Surg (1995) 1.02
Phase III comparative study of vinorelbine combined with doxorubicin versus doxorubicin alone in disseminated metastatic/recurrent breast cancer: National Cancer Institute of Canada Clinical Trials Group Study MA8. J Clin Oncol (2000) 1.02
Extracellular organelles (prostasomes) are immunosuppressive components of human semen. Clin Exp Immunol (1991) 1.02
Synovial cells. A study of the morphology and an examination of protein synthesis of synovial cells. Ann Rheum Dis (1966) 1.02
Association of alpha-macroglobulins with lymphoid cells. Nat New Biol (1973) 1.01
Effect of Corynebacterium parvum on the class and subclass of antibody produced in the response of different strains of mice to sheep erythrocytes. Immunology (1975) 1.00
In vitro studies on the heterogeneity of equine antibodies to human lymphoid tissue. Immunochemistry (1969) 1.00
Dppa3 is a marker of pluripotency and has a human homologue that is expressed in germ cell tumours. Cytogenet Genome Res (2003) 0.99
Community empowerment in the control of lymphatic filariasis in Misima, Milne Bay Province using diethylcarbamazine in combination with albendazole. P N G Med J (2002) 0.99
The effect of anti-lymphocytic IgG on estab- lished autoallergic thyroiditis in rats. Clin Exp Immunol (1969) 0.99
Studies on the Fc receptor bearing cells in a transplanted methylcholanthrene induced mouse fibrosarcoma. Br J Cancer (1976) 0.98
Preliminary studies on the synthesis of alpha2-macroglobulin by human lymphocytes in vitro. Clin Exp Immunol (1974) 0.98
The effect of antilymphocytic antibody on the humoral immune response in different strains of mice. 3. The response to type 3 pneumococcus polysaccharide. Immunology (1973) 0.97
Association of host immunoglobulins with solid tumours in vivo. Br J Cancer (1979) 0.97
Lymphocyte sub-populations in the male genital tract. Br J Urol (1985) 0.97
Validation evidence for three coping measures. J Pers Assess (1995) 0.96
The production and characterisation of a panel of ten murine monoclonal antibodies to human procoagulant factor VIII. Thromb Haemost (1986) 0.96
A fluorescence polarization assay for inhibitors of Hsp90. Anal Biochem (2006) 0.96
Characteristics of peritoneal macrophages induced by asbestos injection. Environ Res (1982) 0.95
Prolonged seated immobility at work is a common risk factor for venous thromboembolism leading to hospital admission. Intern Med J (2008) 0.95
Elimination of normal horse IgG labelled with Iodine-131 in rats receiving horse anti-rat lymphocytic IgG. Nature (1967) 0.95
The association of alpha2-macroglobulin with lymphocyte membranes in chronic lymphocytic leukaemia and other disorders. Clin Exp Immunol (1975) 0.94
The effect of antilymphocytic antibody on the primary immune response of mice to sheep erythrocytes, bovine serum albumin, and type 3 pneumococcus polysaccharide. Transplantation (1971) 0.94
UK-69,578, a novel inhibitor of EC 3.4.24.11 which increases endogenous ANF levels and is natriuretic and diuretic. Biochem Biophys Res Commun (1989) 0.94
Ileal pouch-anal anastomosis: is preoperative anal manometry predictive of postoperative functional outcome? Dis Colon Rectum (1994) 0.93
The role of hepatocyte growth factor and its receptor c-met in interactions between lymphocytes and stromal cells in secondary human lymphoid organs. Immunology (2001) 0.93
Immunosuppression by seminal prostaglandins. Clin Exp Immunol (1989) 0.92
The immunosuppressive properties of sub-fractions of antilymphocytic IgG of equine origin. Immunology (1971) 0.92
Strain variations in the primary humoral response of rats and its susceptibility to inhibition by anti-lymphocytic antibody. Nature (1969) 0.92
Antitumor antibodies and immunoglobulin class and subclass levels in Corynebacterium parvum-treated mice. J Natl Cancer Inst (1976) 0.92
Parallel studies on the effect of anti-lymphocytic antibody on cell mediated and humoral antibody responses in the rat. Clin Exp Immunol (1968) 0.92
Antitumour responses induced by short-term pretreatment with tumour cells. Br J Cancer (1978) 0.92
Trypsin stabilizers in human serum. The role of alpha-2-macroglobulin. Clin Chim Acta (1966) 0.92
Enhancement of terminal B lymphocyte differentiation in vitro by fibroblast-like stromal cells from human spleen. Eur J Immunol (1998) 0.92
Effects of C-reactive protein on human lymphocyte responsiveness. J Immunol (1983) 0.91
Immunocompetent cells in human testis in health and disease. Fertil Steril (1987) 0.91
Role of adhesion molecules in lymphokine-activated killer cell killing of bladder cancer cells: further evidence for a third ligand for leucocyte function-associated antigen-1. Immunology (1992) 0.91
The impact of the quality of laboratory staff on the accuracy of laboratory results. JAMA (1987) 0.91
Interleukin-6 production by bladder tumors is upregulated by BCG immunotherapy. J Urol (1995) 0.91
Intra-epithelial lymphocytes in the normal epididymis. A mechanism for tolerance to sperm auto-antigens? Br J Urol (1984) 0.90
Prognosis of intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer by immunological urinary measurements: statistically weighted syndrome analysis. J Urol (1998) 0.90
HLA-DR expression by high grade superficial bladder cancer treated with BCG. Br J Urol (1989) 0.90
An investigation of factors influencing the in vitro induction of LAK activity against a variety of human bladder cancer cell lines. J Urol (1992) 0.90